Stock VIV AVIVAGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Avivagen Inc.

Equities

VIV

CA05382F2026

Delayed Toronto S.E.
Other stock markets
 09:30:00 2024-03-05 am EST 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Avivagen Inc. -.--% -.--%
2023 Avivagen Inc. Announces New 500 Kg Order for OxC-beta CI
2023 Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA
NE
Canadian Investment Regulatory Organization Trading Halt - VIV
AQ
Avivagen Inc. Announces New 500 Kg Order for OxC-beta
CI
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
CI
Avivagen Brief: Announcing several corporate updates, relating to allowances of patents, a waiver of an interest payment on its senior secured debentures and continuation of the strategic review process
MT
Avivagen Secures New Orders for 1.1 Tons of Oxc-Beta Livestock Product
MT
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product
CI
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
CI
Avivagen Announces Significant Increase in Sales to an Existing Customer
AQ
Avivagen Reports Increase in Sales to Existing Customer
MT
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer
CI
Avivagen Brief: Announcing "Significant" Increase in Sales to an Existing Customer
MT
Avivagen Launches Strategic Review; Comes After Soaring 50% Yesterday
MT
Avivagen Brief: Announcing Review of Strategic Alternatives
MT
Avivagen Announces Review of Strategic Alternatives
CI
Avivagen Inc. Announces Board Changes
CI
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern
MT
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023
CI
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth
AQ
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIV Stock
  4. News Avivagen Inc.